EMOLX | RNWFX | EMOLX / RNWFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 23 years | - |
Gain YTD | 13.065 | 9.971 | 131% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.55M | 64B | 0% |
Annual Yield % from dividends | 1.57 | 1.51 | 104% |
Returns for 1 year | 15.21 | 11.94 | 127% |
Returns for 3 years | N/A | 0.62 | - |
Returns for 5 years | N/A | 15.96 | - |
Returns for 10 years | N/A | 50.39 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PJHRX | 37.57 | N/A | N/A |
PGIM Jennison Health Sciences R | |||
CSCAX | 29.70 | -0.11 | -0.38% |
Cove Street Capital Small Cap Val Instl | |||
GFFDX | 82.79 | -0.61 | -0.73% |
Invesco Global Focus R5 | |||
VADFX | 74.84 | -0.56 | -0.74% |
Invesco Equally-Wtd S&P 500 R6 | |||
VSFCX | 22.37 | -0.32 | -1.41% |
Federated Hermes Clover Small Value C |